Last updated on November 2017

A Double-Masked, Randomized, Multi-Center Phase I/II Study to Evaluate the Efficacy and Safety of Laripep in Subjects with Dry Eye Associated with Sjögren’s Syndrome


Brief description of study

A Double-Masked, Randomized, Multi-Center Phase I/II Study to Evaluate the Efficacy and Safety of Laripep in Subjects with Dry Eye Associated with Sjögren’s Syndrome

Detailed Study Description

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep™ ophthalmic solution versus placebo administered 3 times a day for 4 weeks with subjects with Dry Eye associated with Primary Sjögren’s Syndrome

Clinical Study Identifier: TX14848

Contact Investigators or Research Sites near you

Start Over

Mandy Kessinger

The Eye Care Institute
Louisville, KY USA